Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
COSCIENS Biopharma ( (TSE:CSCI) ) just unveiled an update.
On May 2, 2025, COSCIENS Biopharma Inc. announced plans for its upcoming Annual General and Special Meeting of Security Holders, scheduled for June 26, 2025. The company highlighted its strategic decision to sunset certain programs and focus on the development of its core products, which could impact its market positioning and stakeholder interests. The meeting will be held virtually, and the record date for voting is set for May 27, 2025.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical and nutraceutical products. The company is known for its patented technologies and value-driving products, including oat-based pipeline products and Macrilen® (macimorelin).
YTD Price Performance: 37.36%
Average Trading Volume: 24,139
Technical Sentiment Signal: Buy
Current Market Cap: $11.83M
For detailed information about CSCI stock, go to TipRanks’ Stock Analysis page.